BBK Worldwide Head of Social Strategy Named to PharmaVOICE 100

BOSTON, Aug. 1, 2014 /PRNewswire/ -- BBK Worldwide, a leading clinical trial marketing firm, today announced that its Head of Social Innovation and Strategic Consultation, Aaron Fleishman, was named to PharmaVOICE magazine's annual list of the 100 most inspiring people in life sciences. The award recognizes Mr. Fleishman for his contributions in helping to elevate patient volunteers in research so that their voices are heard.

From blog posts to large-scale awareness initiatives, Mr. Fleishman's efforts with numerous organizations and advocacy groups to better understand patients' thoughts and feelings about what motivates them to join a clinical trial, has resulted in the development of new educational and interactive resources to help improve the overall study participation experience. His contributions to BBK's online healthcare initiative, Calling All Types, a joint project with PatientsLikeMe and the American Diabetes Association to educate individuals living with diabetes about clinical research opportunities, helped create an interactive online health community of more than 400 active members.

"Aaron and his team balance the needs of many key stakeholders – from clinical research sponsors and physicians to advocacy organizations and patient thought leaders – while ensuring that study patients and their caregivers are at the center of every campaign," said Joan F. Bachenheimer, founding principal, BBK Worldwide. "His passion for the industry and his patient-centric approach are an inspiration – for his colleagues, and our clients and partners."

Established ten years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life sciences industry. Nominated by thousands of PharmaVOICE readers, the PharmaVOICE 100 are selected based on well-crafted and comprehensive essays describing how individuals inspired or motivated their colleagues or peers, affected positive changes in their organizations, as well as other factors, such as community and philanthropic activities. The PharmaVOICE 100 represent a broad cross section of industry sectors including pharmaceutical, biopharmaceutical, biotechnology, contract research, clinical trial, research and development, patient education, patient recruitment, advertising, technology and many others.

"Every year we honor the industry's rising stars; those among us working to push boundaries, willing to innovate no matter how challenging, and push for the adoption of new approaches for the betterment of the industry," said Taren Grom, editor and cofounder, PharmaVOICE. "We're pleased to honor Aaron and his work in patient advocacy, a commitment that placed him squarely on this year's PharmaVOICE 100 list."

Follow BBK

• Our blog: http://innovations.bbkworldwide.com/
• On Twitter: @BBKWorldwide
• Tweet this: .@BBKWorldwide social lead @afleishmanbbk honored with #PharmaVOICE100 for #PatientAdvocacy @PharmaVOICE
• Connect with us on LinkedIn

About PharmaVOICE
PharmaVOICE is expressly written and designed to deliver the views, opinions, and insights of executives who are shaping the direction of the dynamic life sciences industry. PharmaVOICE reaches more than 29,000 subscribers every month in print and more than 100,000 readers through its online version, which contains original exclusive bonus content. PharmaVOICE's unique horizontal editorial approach cuts industry silos, providing a holistic overview of the life sciences industry, addressing a range of topics from molecule through market. By engaging compelling personalities from diverse industry sectors, PharmaVOICE provides multiple perspectives on business challenges, trends, and topics. Editorial content sparks dialog, initiates debate, and opens the lines of communication to facilitate and improve business-to-business relationships. PharmaVOICE's multiple-perspective and in-depth original forums, feature articles, topics, and departments are audience-driven. PharmaVOICE provides executives with useful peer-to-peer insights on a broad range of life sciences business practices and topics.

About BBK Worldwide
With more than three decades of experience across a wide variety of therapies and medicines, BBK Worldwide is the global leader in patient recruitment for the clinical trial industry. BBK's latest innovation is the introduction of adaptive recruitment – a new specialty in clinical trial marketing proven to protect global enrollment integrity, specifically within a changing or threatened landscape. BBK is a privately held, women owned business, headquartered in Needham, Mass. For more information, visit: www.bbkworldwide.com.

Photo - http://photos.prnewswire.com/prnh/20140731/132431

SOURCE BBK Worldwide